[1] |
Jeong A, Min JH, Kang YK, et al. Factors associated with quality of life of people with Myasthenia Gravis[J]. PLoS One, 2018, 13(11):e0206754.
|
[2] |
Berrih-Aknin S, Le Panse R. Myasthenia gravis: a comprehensive review of immune dysregulation and etiological mechanisms[J]. J Autoimmun, 2014, 52:90-100.
|
[3] |
Gradolatto A, Nazzal D, Truffault F, et al. Both Treg cells and Tconv cells are defective in the Myasthenia gravis thymus: roles of IL-17 and TNF-α[J]. J Autoimmun, 2014, 52:53-63.
|
[4] |
Walter GJ, Fleskens V, Frederiksen KS, et al. Phenoty-pic, Functional, and Gene Expression Profiling of Peripheral CD45RA+ and CD45RO+ CD4+CD25+CD127(low) Treg Cells in Patients With Chronic Rheumatoid Arthritis[J]. Arthritis Rheumatol, 2016, 68(1):103-116.
|
[5] |
Liu C, Wang Q, Qiu Z, et al. Analysis of mortality and related factors in 2195 adult myasthenia gravis patients in a 10-year follow-up study[J]. Neurol India, 2017, 65(3):518-524.
|
[6] |
Liu J, Lu CX, Zhang F, et al. Expression of ILT3 predicts poor prognosis and is inversely associated with infiltration of CD45RO+ T cells in patients with colorectal cancer[J]. Pathol Res Pract, 2018, 214(10):1621-1625.
|
[7] |
Attia M, Maurer M, Robinet M, et al. Muscle satellite cells are functionally impaired in myasthenia gravis: consequences on muscle regeneration[J]. Acta Neuropathol, 2017, 134(6):869-888.
|
[8] |
荣举, 翁文娟, 林晓瑜, 等. 系统性红斑狼疮患者外周血细胞CD45分子亚型分析[J]. 汕头大学医学院学报, 2016, 29(4):215-217.
|
[9] |
Alahgholi-Hajibehzad M, Kasapoglu P, Jafari R, et al. The role of T regulatory cells in immunopathogenesis of myasthenia gravis: implications for therapeutics[J]. Expert Rev Clin Immunol, 2015, 11(7):859-870.
|
[10] |
Shin DS, Jordan A, Basu S, et al. Regulatory T cells suppress CD4+ T cells through NFAT-dependent transcriptional mechanisms[J]. EMBO Rep, 2014, 15(9):991-999.
|
[11] |
Thiruppathi M, Rowin J, Ganesh B, et al. Impaired regulatory function in circulating CD4(+)CD25(high)CD127(low/-) T cells in patients with myasthenia gravis[J]. Clin Immunol, 2012, 145(3):209-223.
|